Order Article Reprints

Presl J, Havelka P, Weinberger V, Ovesna P, Fekete P, Fruhauf F, Jedryka M, Bystricky B, Strojna A, Volodko N, et al. The Role of HE4 in the Follow-Up of Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer—CEEGOG OX-01 Study. Cancers. 2024; 16(21):3566. https://doi.org/10.3390/cancers16213566

Presl, Jiri, Pavel Havelka, Vit Weinberger, Petra Ovesna, Peter Fekete, Filip Fruhauf, Marcin Jedryka, Branislav Bystricky, Aleksandra Strojna, Nataliya Volodko, and et al. 2024. "The Role of HE4 in the Follow-Up of Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer—CEEGOG OX-01 Study" Cancers 16, no. 21: 3566. https://doi.org/10.3390/cancers16213566

Presl, J., Havelka, P., Weinberger, V., Ovesna, P., Fekete, P., Fruhauf, F., Jedryka, M., Bystricky, B., Strojna, A., Volodko, N., Matylevich, O., Herboltova, P., Blecharz, P., Kalist, V., Ehrlichova, L., Stranik, P., Masak, L., Poncova, R., Czekanski, A., ... Kostun, J. (2024). The Role of HE4 in the Follow-Up of Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer—CEEGOG OX-01 Study. Cancers, 16(21), 3566. https://doi.org/10.3390/cancers16213566